Skip to main content
. 2021 Aug 30;74(5):2759–2773. doi: 10.1002/hep.32030

TABLE 1.

Demographics in 194 Human LTs With SRA <15% versus SRA ≥15%

SRA <15% SRA ≥15% P Value
n = 140 n = 54
Recipient factors
Age (years) 58 (18‐78) 60 (24‐74) 0.086
Sex (female/male) 47/93 20/34 0.649
BMI (kg/m2) 26.9 (16.1‐47.5) 26.6 (17.5‐41.1) 0.818
Comorbidity
DM 49 (35.0) 16 (29.6) 0.478
HTN 60 (42.9) 24 (44.4) 0.841
CAD 25 (17.9) 10 (18.5) 0.914
Underlying liver disease 0.591
HBV 7 (5.0) 2 (3.7)
HCV 55 (39.3) 22 (40.7)
EtOH 24 (17.1) 10 (18.5)
NASH 16 (11.4) 8 (14.8)
ALF 9 (6.4) 3 (5.6)
PBC 2 (1.4) 3 (5.6)
Others 27 (19.3) 6 (11.1)
Preoperative hospital stay (days) 5 (0‐168) 3 (0‐56) 0.978
Preoperative ICU admission 75 (53.6) 26 (48.1) 0.498
Laboratory data at LT
AST (IU/L) 67 (18‐6,705) 57 (22‐1,918) 0.180
ALT (IU/L) 35 (9‐6,850) 37 (8‐3,705) 0.993
Laboratory MELD 30.9 (6.4‐46.2) 31.4 (6.4‐45.9) 0.922
Donor factors
Age (years) 35 (13‐74) 43 (16‐72) 0.074
Sex (female/male) 62/78 18/36 0.165
BMI (kg/m2) 26.3 (17.3‐53.0) 25.8 (19.6‐38.7) 0.907
Comorbidity
DM 8 (5.7) 8 (14 .8) 0.039
HTN 36 (25.7) 14 (25.9) 0.976
CAD 8 (5.8) 2 (3.7) 0.729
Cause of death 0.814
Trauma 49 (35.0) 22 (40.7)
CVS 48 (34.3) 18 (33.3)
Anoxia 41 (29.3) 13 (24.1)
Others 2 (1.4) 1 (1.9)
Laboratory data at procurement
AST (IU/L) 38 (9‐483) 49 (12‐260) 0.113
ALT (IU/L) 32 (8‐730) 32 (11‐74) 0.759
DCD 7 (5.0) 3 (5.6) >0.999
HCV Ab positive 3 (2.1%) 2 (3.7%) 0.619
Cold ischemia time (min) 440 (138‐878) 419 (234‐757) 0.590
Warm ischemia time (min) 48 (24‐79) 49 (23‐77) 0.834
Large droplet steatosis ≥30% 4 (2.9) 4 (7.4) 0.222
Fibrosis on H&E and trichrome (≥F1) 1 (0.7) 0 >0.999

Bold represent statistical significance.

Abbreviations: ALF, acute liver failure; CAD, coronary artery disease; CVS, cerebrovascular stroke; DM, diabetes mellitus; EtOH, alcohol‐associated (ethanol) liver disease; HTN, hypertension; ICU, intensive care unit; PBC, primary biliary cholangitis.